List of Excipients in API omeprazole magnesium, amoxicillin and rifabutin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing omeprazole magnesium, amoxicillin and rifabutin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| RedHill Biopharma Ltd | TALICIA | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 | CROSPOVIDONE | 2027-11-01 |
| RedHill Biopharma Ltd | TALICIA | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 | FD&C RED NO. 3 | 2027-11-01 |
| RedHill Biopharma Ltd | TALICIA | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 | FD&C YELLOW NO. 6 | 2027-11-01 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for omeprazole magnesium, amoxicillin and rifabutin
Excipient focus: CROSPOVIDONE
omeprazole magnesium, amoxicillin and rifabutin drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
omeprazole magnesium, amoxicillin and rifabutin drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
omeprazole magnesium, amoxicillin and rifabutin drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
omeprazole magnesium, amoxicillin and rifabutin drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
omeprazole magnesium, amoxicillin and rifabutin drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
omeprazole magnesium, amoxicillin and rifabutin drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
omeprazole magnesium, amoxicillin and rifabutin drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
omeprazole magnesium, amoxicillin and rifabutin drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEGLUMINE
omeprazole magnesium, amoxicillin and rifabutin drug variants containing MEGLUMINE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing MEGLUMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
omeprazole magnesium, amoxicillin and rifabutin drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
omeprazole magnesium, amoxicillin and rifabutin drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
omeprazole magnesium, amoxicillin and rifabutin drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
omeprazole magnesium, amoxicillin and rifabutin drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
omeprazole magnesium, amoxicillin and rifabutin drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
omeprazole magnesium, amoxicillin and rifabutin drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
omeprazole magnesium, amoxicillin and rifabutin drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
omeprazole magnesium, amoxicillin and rifabutin drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| RedHill Biopharma Ltd | omeprazole magnesium, amoxicillin and rifabutin | 57841-1150 |
| >Company | >Ingredient | >NDC |
omeprazole magnesium, amoxicillin and rifabutin drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links